Taking a folic acid supplement daily before pregnancy may reduce the risk of gestational, or pregnancy-related, diabetes, according to a recent study.
A large study of more than 21,000 people finds that training emergency medical services (EMS) agencies to implement prehospital guidelines for traumatic brain injury (TBI) may help improve survival in patients with severe head trauma.
People eating ultra-processed foods ate more calories and gained more weight than when they ate a minimally processed diet, according to results from an NIH study.
In a study of healthy volunteers, NIH researchers found that our brains may solidify the memories of new skills we just practiced a few seconds earlier by taking a short rest. The results highlight the critically important role rest may play in learning.
With funding through the BRAIN Initiative, researchers developed a way to deliver an artificial blood supply to the isolated postmortem brain of a pig, preventing the degradation that would otherwise destroy many cellular and molecular functions and render it unsuitable for study.
A small clinical trial has shown that gene therapy can safely correct the immune systems of infants newly diagnosed with a rare, life-threatening inherited disorder in which infection-fighting immune cells do not develop or function normally.
A new study led by scientists at NCI sheds light on one way tumors may continue to grow despite the presence of cancer-killing immune cells. The findings, published Mar. 29 in Science, suggest a way to enhance the effectiveness of immunotherapies for cancer treatment.
A drug approved to treat a severe form of asthma dramatically improved the health of people with rare chronic immune disorders called hypereosinophilic syndromes (HES) in whom other treatments were ineffective or intolerable.
The first clinical trial of an innovative universal influenza vaccine candidate is examining the vaccine’s safety and tolerability as well as its ability to induce an immune response in healthy volunteers. Scientists at NIAID developed the experimental vaccine.
Survivors of Ebola virus disease (EVD) in Liberia had a higher prevalence of certain health issues when compared to a control group of household and community members who did not have a history of EVD.